Equities

PainReform Ltd

PRFX:NAQ

PainReform Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.7711
  • Today's Change0.019 / 2.47%
  • Shares traded549.68k
  • 1 Year change-96.64%
  • Beta0.5733
Data delayed at least 15 minutes, as of Sep 20 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, PainReform Ltd (PRFX:NAQ) closed at 0.7711, 6.95% above its 52-week low of 0.721, set on Sep 18, 2024.
52-week range
Today
0.721Sep 18 202423.34Sep 20 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.7501
High0.79
Low0.732
Bid0.5803
Offer0.600
Previous close0.7525
Average volume1.29m
Shares outstanding1.17m
Free float373.63k
P/E (TTM)--
Market cap881.21k USD
EPS (TTM)-41.92
USD
Data delayed at least 15 minutes, as of Sep 20 2024 20:59 BST.
More ▼

Events & Activity

  • PRFX:NAQ trading volume exceeds daily average by +173.68%
  • PRFX:NAQ price reached a new 52-week low of 0.755 at 11:10 BST
  • PRFX:NAQ price moved over +2.30% to 0.89
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.